The Influence of Having Bariatric Surgery on the Pharmacokinetics, Safety and Efficacy of the Novel Non-nucleoside Reverse Transcriptase Inhibitor Doravirine

Name: The Influence of Having Bariatric Surgery on the Pharmacokinetics, Safety and Efficacy of the Novel Non-nucleoside Reverse Transcriptase Inhibitor Doravirine
Published: 2022
License: Public Domain

Radboud University Medical Center · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

hiv-infections na pharmacokinetics

hiv infections, bariatric surgery candidate, doravirine, pharmacokinetics, interventional, na

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

The Influence of Having Bariatric Surgery on the Pharmacokinetics, Safety and Efficacy of the Novel Non-nucleoside Reverse Transcriptase Inhibitor Doravirine

Related documents